Retail crime in England and Wales reached 529,994 shoplifting incidents in the year to June 2025, up 13% on the previous year ...

ONS-5010 is an investigational ophthalmic formulation of bevacizumab which, if approved, will be branded as LYTENAVA™ (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (wet ...

KC Joyner looks at rest-of-season schedules to locate trade targets and players to ship out before their value plummets.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of ...

Experience the thrill of Disneyland like never before! Watch as we ride 4 E-ticket attractions in just one hour and explore how empty the park really is. Perfect for Disney fans and theme park ...

The stats body comes in for criticism but they perform a remarkable public service - and not just for financial journalists ...

On the set of Euphoria Season 3, Sweeney swapped Cassie Howard's heels for the Ugg Scuffette II slippers. Consider these $100 ...

Actor and comedian Jim Gaffigan’s “Everything is Wonderful!” tour is coming to the Walmart AMP next year. The Grammy and Emmy-winning performer will hit the stage at the Walmart AMP in Rogers on ...

The hit feel-good comedy, “St. Denis Medical,” returns for Season 2, premiering Monday, Nov. 3, at 8 p.m. ET on NBC.

Outlook Therapeutics (OTLK) announced it has re-submitted its Biologics License Application, BLA, to the U.S. Food and Drug Administration, FDA, for ONS-5010, after receiving the official minutes from ...

BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint ...

Protect your luxury car with top Chola MS add-ons- from zero depreciation to engine cover, ensure complete financial security and peace of mind ...